Doximity, Inc. (NYSE: DOCS) Stock Competitors & Peer Comparison
See DOCS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DOCS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DOCS | $21.39 | -3.69% | 4B | 14.07 | $1.53 | N/A |
| VEEV | $195.19 | -1.11% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $62.79 | -4.43% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $72.37 | +6.17% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $238.98 | +4.49% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $47.81 | -10.79% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.47 | +2.52% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $86.24 | +0.30% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
DOCS vs VEEV Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while VEEV trades at $195.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas VEEV's P/E ratio is 23.46. In terms of profitability, DOCS's ROE is +0.19%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, DOCS is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
DOCS vs GEHC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while GEHC trades at $62.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas GEHC's P/E ratio is 13.83. In terms of profitability, DOCS's ROE is +0.19%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, DOCS is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
DOCS vs GEHCV Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas GEHCV's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, DOCS is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
DOCS vs BTSG Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while BTSG trades at $72.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas BTSG's P/E ratio is 57.01. In terms of profitability, DOCS's ROE is +0.19%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, DOCS is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
DOCS vs BTSGU Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while BTSGU trades at $238.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, DOCS's ROE is +0.19%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
DOCS vs TEM Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while TEM trades at $47.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas TEM's P/E ratio is -104.94. In terms of profitability, DOCS's ROE is +0.19%, compared to TEM's ROE of -0.70%. Regarding short-term risk, DOCS is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
DOCS vs SGFY Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SGFY's P/E ratio is 70.91. In terms of profitability, DOCS's ROE is +0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, DOCS is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
DOCS vs HQY Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HQY trades at $97.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HQY's P/E ratio is 23.06. In terms of profitability, DOCS's ROE is +0.19%, compared to HQY's ROE of +0.11%. Regarding short-term risk, DOCS is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
DOCS vs HNGE Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HNGE trades at $86.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HNGE's P/E ratio is 44.66. In terms of profitability, DOCS's ROE is +0.19%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, DOCS is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
DOCS vs RCM Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas RCM's P/E ratio is -102.21. In terms of profitability, DOCS's ROE is +0.19%, compared to RCM's ROE of +0.00%. Regarding short-term risk, DOCS is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
DOCS vs TXG Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while TXG trades at $42.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas TXG's P/E ratio is -257.29. In terms of profitability, DOCS's ROE is +0.19%, compared to TXG's ROE of -0.03%. Regarding short-term risk, DOCS is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check TXG's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
DOCS vs ONEM Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ONEM's P/E ratio is -7.77. In terms of profitability, DOCS's ROE is +0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, DOCS is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
DOCS vs PRVA Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while PRVA trades at $26.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas PRVA's P/E ratio is 168.13. In terms of profitability, DOCS's ROE is +0.19%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, DOCS is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
DOCS vs PGNY Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while PGNY trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas PGNY's P/E ratio is 23.31. In terms of profitability, DOCS's ROE is +0.19%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, DOCS is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
DOCS vs HTFL Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HTFL trades at $24.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HTFL's P/E ratio is -12.92. In terms of profitability, DOCS's ROE is +0.19%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, DOCS is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
DOCS vs WGS Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while WGS trades at $60.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas WGS's P/E ratio is 74.68. In terms of profitability, DOCS's ROE is +0.19%, compared to WGS's ROE of -0.28%. Regarding short-term risk, DOCS is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
DOCS vs TDOC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while TDOC trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas TDOC's P/E ratio is -10.47. In terms of profitability, DOCS's ROE is +0.19%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, DOCS is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
DOCS vs NXGN Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas NXGN's P/E ratio is -266.00. In terms of profitability, DOCS's ROE is +0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, DOCS is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
DOCS vs OMDA Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while OMDA trades at $23.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas OMDA's P/E ratio is 338.57. In terms of profitability, DOCS's ROE is +0.19%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, DOCS is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
DOCS vs AGTI Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas AGTI's P/E ratio is -71.79. In terms of profitability, DOCS's ROE is +0.19%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, DOCS is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
DOCS vs GDRX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while GDRX trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas GDRX's P/E ratio is 9.52. In terms of profitability, DOCS's ROE is +0.19%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, DOCS is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
DOCS vs CERT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CERT trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CERT's P/E ratio is 17.77. In terms of profitability, DOCS's ROE is +0.19%, compared to CERT's ROE of -0.01%. Regarding short-term risk, DOCS is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
DOCS vs CCLDO Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CCLDO's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
DOCS vs HSTM Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HSTM trades at $28.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HSTM's P/E ratio is 38.08. In terms of profitability, DOCS's ROE is +0.19%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, DOCS is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
DOCS vs WGSWW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.19%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, DOCS is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
DOCS vs PHR Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, PHR has a market cap of 662M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while PHR trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas PHR's P/E ratio is 38.25. In terms of profitability, DOCS's ROE is +0.19%, compared to PHR's ROE of +0.03%. Regarding short-term risk, DOCS is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
DOCS vs EVH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while EVH trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas EVH's P/E ratio is 580.00. In terms of profitability, DOCS's ROE is +0.19%, compared to EVH's ROE of -0.78%. Regarding short-term risk, DOCS is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
DOCS vs MPLN-WT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, DOCS is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
DOCS vs ACCD Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ACCD's P/E ratio is -3.08. In terms of profitability, DOCS's ROE is +0.19%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, DOCS is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
DOCS vs SHCR Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SHCR's P/E ratio is -3.76. In terms of profitability, DOCS's ROE is +0.19%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, DOCS is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
DOCS vs CTEV Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CTEV trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CTEV's P/E ratio is -2.33. In terms of profitability, DOCS's ROE is +0.19%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, DOCS is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
DOCS vs NRC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while NRC trades at $21.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas NRC's P/E ratio is 26.56. In terms of profitability, DOCS's ROE is +0.19%, compared to NRC's ROE of +0.57%. Regarding short-term risk, DOCS is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
DOCS vs SOPH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SOPH trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SOPH's P/E ratio is -11.29. In terms of profitability, DOCS's ROE is +0.19%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, DOCS is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
DOCS vs SLGC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SLGC's P/E ratio is -3.04. In terms of profitability, DOCS's ROE is +0.19%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, DOCS is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
DOCS vs SLGCW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, DOCS's ROE is +0.19%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, DOCS is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
DOCS vs TBRG Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas TBRG's P/E ratio is 9.37. In terms of profitability, DOCS's ROE is +0.19%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, DOCS is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
DOCS vs MPLN Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MPLN's P/E ratio is -0.23. In terms of profitability, DOCS's ROE is +0.19%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, DOCS is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
DOCS vs SLP Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SLP's P/E ratio is 20.72. In terms of profitability, DOCS's ROE is +0.19%, compared to SLP's ROE of +0.06%. Regarding short-term risk, DOCS is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
DOCS vs TRHC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas TRHC's P/E ratio is -4.27. In terms of profitability, DOCS's ROE is +0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, DOCS is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
DOCS vs SMFR Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SMFR's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, DOCS is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
DOCS vs SPOK Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SPOK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SPOK's P/E ratio is 17.73. In terms of profitability, DOCS's ROE is +0.19%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, DOCS is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
DOCS vs SY Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SY trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SY's P/E ratio is -5.09. In terms of profitability, DOCS's ROE is +0.19%, compared to SY's ROE of -0.16%. Regarding short-term risk, DOCS is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SY's competition here
American Well Corporation (NYSE: AMWL)
DOCS vs AMWL Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while AMWL trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas AMWL's P/E ratio is -2.54. In terms of profitability, DOCS's ROE is +0.19%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, DOCS is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
DOCS vs HCAT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HCAT trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HCAT's P/E ratio is 11.25. In terms of profitability, DOCS's ROE is +0.19%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, DOCS is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
DOCS vs CPSI Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CPSI's P/E ratio is -183.80. In terms of profitability, DOCS's ROE is +0.19%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, DOCS is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
DOCS vs OPRX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while OPRX trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas OPRX's P/E ratio is 6.14. In terms of profitability, DOCS's ROE is +0.19%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, DOCS is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
DOCS vs AUGX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas AUGX's P/E ratio is -4.99. In terms of profitability, DOCS's ROE is +0.19%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, DOCS is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
DOCS vs CCLD Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CCLD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CCLD's P/E ratio is 8.59. In terms of profitability, DOCS's ROE is +0.19%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
DOCS vs DH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while DH trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas DH's P/E ratio is 2.92. In terms of profitability, DOCS's ROE is +0.19%, compared to DH's ROE of -0.67%. Regarding short-term risk, DOCS is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
DOCS vs FORA Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas FORA's P/E ratio is -24.11. In terms of profitability, DOCS's ROE is +0.19%, compared to FORA's ROE of -0.17%. Regarding short-term risk, DOCS is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
DOCS vs CCLDP Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CCLDP's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, DOCS is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
DOCS vs ONMD Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ONMD trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ONMD's P/E ratio is -4.53. In terms of profitability, DOCS's ROE is +0.19%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, DOCS is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
DOCS vs SNCE Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SNCE's P/E ratio is -0.27. In terms of profitability, DOCS's ROE is +0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, DOCS is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
DOCS vs AKLI Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas AKLI's P/E ratio is -0.71. In terms of profitability, DOCS's ROE is +0.19%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, DOCS is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
DOCS vs SHLT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SHLT's P/E ratio is -3.87. In terms of profitability, DOCS's ROE is +0.19%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, DOCS is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
DOCS vs SHCRW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.19%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, DOCS is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
DOCS vs ONMDW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ONMDW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, DOCS is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
DOCS vs STRM Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas STRM's P/E ratio is -2.40. In terms of profitability, DOCS's ROE is +0.19%, compared to STRM's ROE of -0.32%. Regarding short-term risk, DOCS is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
DOCS vs RNLX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas RNLX's P/E ratio is -0.33. In terms of profitability, DOCS's ROE is +0.19%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, DOCS is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
DOCS vs LIFW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas LIFW's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.19%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
DOCS vs EUDA Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while EUDA trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas EUDA's P/E ratio is -21.32. In terms of profitability, DOCS's ROE is +0.19%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, DOCS is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
DOCS vs BBLN Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas BBLN's P/E ratio is -0.04. In terms of profitability, DOCS's ROE is +0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, DOCS is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
DOCS vs BEATW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas BEATW's P/E ratio is -0.04. In terms of profitability, DOCS's ROE is +0.19%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, DOCS is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
DOCS vs ETAO Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ETAO's P/E ratio is -0.01. In terms of profitability, DOCS's ROE is +0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, DOCS is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
DOCS vs BFRG Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while BFRG trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas BFRG's P/E ratio is -1.20. In terms of profitability, DOCS's ROE is +0.19%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, DOCS is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
DOCS vs HLTH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HLTH's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.19%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, DOCS is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
DOCS vs SCNX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas SCNX's P/E ratio is -0.16. In terms of profitability, DOCS's ROE is +0.19%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, DOCS is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
DOCS vs UPH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas UPH's P/E ratio is -0.07. In terms of profitability, DOCS's ROE is +0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, DOCS is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
DOCS vs UPH-WT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, DOCS is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
DOCS vs MGRX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MGRX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MGRX's P/E ratio is -0.31. In terms of profitability, DOCS's ROE is +0.19%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, DOCS is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
DOCS vs PEAR Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas PEAR's P/E ratio is -0.08. In terms of profitability, DOCS's ROE is +0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
DOCS vs PEARW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas PEARW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
DOCS vs OTRK Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas OTRK's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.19%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, DOCS is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
DOCS vs VSEEW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, DOCS's ROE is +0.19%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, DOCS is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
DOCS vs HCTI Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while HCTI trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas HCTI's P/E ratio is -0.23. In terms of profitability, DOCS's ROE is +0.19%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, DOCS is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
DOCS vs CMAX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CMAX's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.19%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, DOCS is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
DOCS vs VSEE Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas VSEE's P/E ratio is -0.19. In terms of profitability, DOCS's ROE is +0.19%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, DOCS is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
DOCS vs ACON Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ACON trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ACON's P/E ratio is -0.24. In terms of profitability, DOCS's ROE is +0.19%, compared to ACON's ROE of -0.54%. Regarding short-term risk, DOCS is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
DOCS vs LIFWZ Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
DOCS vs EUDAW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, DOCS's ROE is +0.19%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, DOCS is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
DOCS vs WORX Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas WORX's P/E ratio is -0.76. In terms of profitability, DOCS's ROE is +0.19%, compared to WORX's ROE of -0.65%. Regarding short-term risk, DOCS is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
DOCS vs MSPRZ Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, DOCS is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
DOCS vs KERN Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas KERN's P/E ratio is -0.01. In terms of profitability, DOCS's ROE is +0.19%, compared to KERN's ROE of -0.17%. Regarding short-term risk, DOCS is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
DOCS vs KERNW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas KERNW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.19%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, DOCS is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
DOCS vs LIFWW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas LIFWW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
DOCS vs ZCMD Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ZCMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, DOCS's ROE is +0.19%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, DOCS is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
DOCS vs CMAXW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CMAXW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, DOCS is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
DOCS vs ACONW Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas ACONW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, DOCS is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
DOCS vs MTBCO Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MTBCO's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
DOCS vs MSPRV Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MSPRV's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MSPRV's ROE of N/A. Regarding short-term risk, DOCS is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
DOCS vs MTBCP Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MTBCP's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
DOCS vs MTBC Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas MTBC's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, DOCS is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
DOCS vs CHNG Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CHNG's P/E ratio is -152.72. In terms of profitability, DOCS's ROE is +0.19%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, DOCS is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
DOCS vs CHNGU Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CHNGU's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, DOCS is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
DOCS vs CNVY Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CNVY's P/E ratio is -71.50. In terms of profitability, DOCS's ROE is +0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, DOCS is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
DOCS vs NAVA Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas NAVA's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.19%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, DOCS is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for DOCS.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
DOCS vs CERN Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CERN has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CERN's P/E ratio is 55.84. In terms of profitability, DOCS's ROE is +0.19%, compared to CERN's ROE of +0.14%. Regarding short-term risk, DOCS is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
DOCS vs CSLT Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas CSLT's P/E ratio is -37.27. In terms of profitability, DOCS's ROE is +0.19%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, DOCS is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
DOCS vs NH Comparison July 2026
Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCS stands at 4B. In comparison, NH has a market cap of 0. Regarding current trading prices, DOCS is priced at $21.39 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCS currently has a P/E ratio of 14.07, whereas NH's P/E ratio is -0.12. In terms of profitability, DOCS's ROE is +0.19%, compared to NH's ROE of +0.35%. Regarding short-term risk, DOCS is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check NH's competition here